← Back to Search

Behavioural Intervention

Treatment Group for Neurologic Gait Disorders (Flicker w FOG Trial)

N/A

Waitlist Available

Led By Stewart Factor, DO

Research Sponsored by Emory University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 6 months

Awards & highlights

Flicker w FOG Trial Summary

"This trial aims to study the safety and effectiveness of special eyewear and earphones that emit visual and auditory stimuli in the gamma range on patients with Parkinson's disease. The goal is to reduce a walking

Who is the study for?

This trial is for Parkinson's disease patients who experience freezing of gait (FOG), a condition where they feel their feet are 'glued' to the floor. Participants should have cognitive function good enough to follow study procedures and provide consent.Check my eligibility

What is being tested?

The study tests special eyewear and earphones that emit gamma flicker stimuli, used for one hour daily. It aims to see if this non-drug approach can reduce FOG by affecting amyloid levels in spinal fluid, which are high in such patients.See study design

What are the potential side effects?

Potential side effects may include discomfort from wearing the device or sensory overload due to the gamma flicker stimulus. However, specific side effects will be monitored as part of the safety assessment.

Flicker w FOG Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 6 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 6 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Number of participants compliant with the study procedures

Number of participants with Adverse events

Secondary outcome measures

Change in subjective changes in FOG.

Change in the MDS-Unified Parkinson's Disease Rating Scale (MDS-UPDRS) scale in participants with PD

Change in the freezing of gait severity in participants with PD.

Other outcome measures

Change in the effects of driving gamma on cerebrospinal fluid (CSF) amyloid levels in patients with PD-FOG

Change in the effects of driving gamma on cerebrospinal fluid (CSF) inflammatory markers levels in patients with PD-FOG

Flicker w FOG Trial Design

2Treatment groups

Experimental Treatment

Placebo Group

Group I: Treatment GroupExperimental Treatment1 Intervention

Participants will receive flicker exposure (via a light and sound device-based stimulation)

Group II: Control GroupPlacebo Group1 Intervention

Participants will receive sham stimulation

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Emory UniversityLead Sponsor

1,641 Previous Clinical Trials

2,561,874 Total Patients Enrolled

Parkinson's FoundationOTHER

11 Previous Clinical Trials

1,020,856 Total Patients Enrolled

Stewart Factor, DOPrincipal InvestigatorEmory University

1 Previous Clinical Trials

60 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are patients currently eligible to enroll in this research study?

"Per the data available on clinicaltrials.gov, this particular research endeavor is currently not in need of participants. It was initially listed on March 1st, 2024 and last modified on February 28th, 2024. Despite this trial no longer seeking enrollees, there are a total of 655 alternative studies actively searching for suitable candidates at present."

Answered by AI

What are the eligibility criteria for individuals to participate in this clinical study?

"Individuals aged between 50 and 75 years with a confirmed diagnosis of Parkinson's disease are eligible for participation in this study. A total of 28 participants will be recruited for the clinical trial."

Answered by AI

Is this medical research study open to individuals who have reached the age of 18 and older?

"Individuals aged between 50 and 75 are eligible for participation in this research. There are a total of 41 trials catering to those under 18 years old, while there are approximately 640 trials available for participants over the age of 65."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Gamma Sensory Flicker for Parkinson's Disease Patients With Freezing of Gait

Stewart Factor 2024. "Gamma Sensory Flicker for Parkinson's Disease Patients With Freezing of Gait". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06295458.

All > Autonomic Dysfunction